MedPath

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Completed
Conditions
Skin Mycoses
Registration Number
NCT00722189
Lead Sponsor
LEO Pharma
Brief Summary

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
900
Inclusion Criteria
  • Diagnosis of skin mycosis
Exclusion Criteria
  • Allergies to study medication

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physicianBaseline to end of study
Secondary Outcome Measures
NameTimeMethod
Patient satisfactionBaseline to end of study

Trial Locations

Locations (1)

Kashkin Clinical Research Mycological Institute

🇷🇺

St Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath